This is an Application Brief and does not contain a detailed Experimental section.
This application brief highlights the scaling-up of beta-blockers in TFA.
Compounds used in this study:
1. Nadolol (100 mg/mL)
2. Metoprolol (100 mg/mL)
3. Propranolol (50 mg/mL)
Column: |
SunFire C18 4.6 x 50 mm, 5 μm (p/n: 186002557) 19 x 50 mm, 5 μm (p/n: 186002566) |
Mobile phase A: |
0.1% TFA in Water |
Mobile phase B: |
0.1% TFA in ACN |
Temperature: |
Ambient |
Detection: |
UV @ 260 nm |
Instrument: |
AutoPurification System |
WA41886, May 2005